Masaya Tachibana Selected Research

Masaya Tachibana Research Topics

Disease

9	Alzheimer Disease (Alzheimer's Disease) 10/2020 - 05/2015
4	Neoplasms (Cancer) 11/2021 - 01/2018
2	Autism Spectrum Disorder 05/2018 - 03/2013
2	Atrial Fibrillation 09/2017 - 05/2012
2	Hemorrhage 05/2012 - 05/2011
1	Carcinogenesis 06/2022
1	Glioma (Gliomas) 06/2022
1	Liposarcoma 11/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2021
1	Lymphoma (Lymphomas) 06/2021
1	Inflammation (Inflammations) 11/2019
1	Weight Loss (Weight Reduction) 03/2016
1	Liver Failure 03/2016
1	Hepatomegaly 03/2016
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2016
1	Gliosis 05/2015
1	Mental Disorders (Mental Disorder) 01/2015
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2015
1	Headache (Headaches) 01/2013
1	Infections 01/2013
1	Chickenpox 01/2013
1	Multiple Sclerosis 01/2013
1	Paralysis (Palsy) 01/2013
1	Relapsing-Remitting Multiple Sclerosis 01/2013
1	Stroke (Strokes) 05/2012
1	Venous Thromboembolism 05/2012
1	Embolism (Embolus) 05/2012
1	Drug-Related Side Effects and Adverse Reactions 10/2010
1	Ischemia 01/2005

Drug/Important Bio-Agent (IBA)

4	Amyloid (Amyloid Fibrils)IBA 10/2020 - 03/2016
3	Apolipoproteins E (ApoE)IBA 01/2020 - 05/2015
3	Apolipoprotein E4IBA 01/2019 - 05/2015
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 05/2012
2	milademetanIBA 11/2021 - 06/2021
2	ApolipoproteinsIBA 01/2019 - 05/2015
2	Peptides (Polypeptides)IBA 01/2019 - 03/2016
2	Proteins (Proteins, Gene)FDA Link 05/2018 - 01/2017
2	edoxabanIBA 09/2017 - 05/2012
1	alpha-hydroxyglutarateIBA 06/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 06/2022
1	Apolipoprotein E2IBA 10/2020
1	taletrectinibIBA 01/2020
1	LipopolysaccharidesIBA 11/2019
1	Nonsense Codon (Nonsense Mutation)IBA 11/2019
1	AntibodiesIBA 05/2018
1	LigandsIBA 05/2018
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2018
1	Digoxin (Digitek)FDA LinkGeneric 01/2018
1	Warfarin (Coumadin)FDA LinkGeneric 01/2018
1	Cytochrome P-450 CYP2C19IBA 01/2018
1	ARQ 197IBA 01/2018
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 01/2018
1	Caffeine (No Doz)FDA LinkGeneric 01/2018
1	Cytochrome P-450 CYP3AIBA 01/2018
1	Omeprazole (Prilosec)FDA LinkGeneric 01/2018
1	Cytochrome P-450 CYP2C9IBA 01/2018
1	Midazolam (Versed)FDA LinkGeneric 01/2018
1	Factor Xa InhibitorsIBA 09/2017
1	CreatinineIBA 09/2017
1	LDL Receptors (LDL Receptor)IBA 01/2017
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 03/2016
1	Bexarotene (LGD1069)FDA Link 03/2016
1	Protein Isoforms (Isoforms)IBA 05/2015
1	Apolipoprotein E3IBA 05/2015
1	Oxytocin (Pitocin)FDA LinkGeneric 03/2013
1	GadoliniumIBA 01/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013
1	Methylprednisolone FDA LinkGeneric 01/2013
1	Azathioprine (Imuran)FDA LinkGeneric 01/2013
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2013
1	Factor Xa (Coagulation Factor Xa)IBA 05/2012
1	Pharmaceutical PreparationsIBA 05/2011
1	Carboxylic AcidsIBA 10/2010
1	GlucuronidesIBA 10/2010
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2005
1	IndazolesIBA 01/2005
1	3- (2- (4- (3- chloro- 2- methylphenyl)1- piperazinyl)ethyl)5,6- dimethoxy- 1- (4- imidazolylmethyl)- 1H- indazol dihydrochloride 3.5 hydrateIBA 01/2005

Therapy/Procedure

3	Therapeutics 06/2021 - 01/2013
1	Drug Therapy (Chemotherapy) 06/2022
1	Radiotherapy 06/2022
1	Drug Tapering 05/2012